Literature DB >> 3190203

New class of antifungal agents: jasplakinolide, a cyclodepsipeptide from the marine sponge, Jaspis species.

V R Scott1, R Boehme, T R Matthews.   

Abstract

Jasplakinolide is a cyclodepsipeptide which represents a new class of antifungal agents with potent activity against Candida albicans. Jasplakinolide is fungicidal against C. albicans with both a MIC and a minimum lethal concentration of 25 micrograms/ml in a broth dilution assay. This activity compares to that of the imidazole miconazole nitrate, which had a MIC of 6.2 micrograms/ml and a minimum lethal concentration of 50 micrograms/ml in the same assay. Topical administration of 2% jasplakinolide cream against a murine vaginal C. albicans infection was equivalent in efficacy to administration of miconazole nitrate at 2%. Subcutaneous administration of jasplakinolide was not effective against a systemic murine C. albicans infection.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3190203      PMCID: PMC172368          DOI: 10.1128/AAC.32.8.1154

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  6 in total

1.  [Chemotherapy of vaginal trichomoniasis and candidiasis in mice].

Authors:  A Wildfeuer
Journal:  Arzneimittelforschung       Date:  1974-06

2.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

3.  Serial dilution antibiotic sensitivity testing with the microtitrator system.

Authors:  J H Marymont; R M Wentz
Journal:  Am J Clin Pathol       Date:  1966-05       Impact factor: 2.493

4.  Pharmacokinetics of imidazole antimycotics.

Authors:  M Plempel
Journal:  Postgrad Med J       Date:  1979-09       Impact factor: 2.401

5.  Mechanisms of action of the antimycotic imidazoles.

Authors:  I J Sud; D S Feingold
Journal:  J Invest Dermatol       Date:  1981-06       Impact factor: 8.551

6.  Protective effect of muramyl dipeptide analogs against infections of Pseudomonas aeruginosa or Candida albicans in mice.

Authors:  E B Fraser-Smith; T R Matthews
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

  6 in total
  23 in total

1.  The actin cytoskeleton and cytotoxic T lymphocytes: evidence for multiple roles that could affect granule exocytosis-dependent target cell killing.

Authors:  Taras A Lyubchenko; Georjeana A Wurth; Adam Zweifach
Journal:  J Physiol       Date:  2003-02-07       Impact factor: 5.182

2.  Targeting MRTF/SRF in CAP2-dependent dilated cardiomyopathy delays disease onset.

Authors:  Yao Xiong; Kenneth Bedi; Simon Berritt; Bennette K Attipoe; Thomas G Brooks; Kevin Wang; Kenneth B Margulies; Jeffrey Field
Journal:  JCI Insight       Date:  2019-03-21

3.  Small-molecule inhibitors of the budded-to-hyphal-form transition in the pathogenic yeast Candida albicans.

Authors:  Kurt A Toenjes; Suzanne M Munsee; Ashraf S Ibrahim; Rachel Jeffrey; John E Edwards; Douglas I Johnson
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

4.  Tyrosine kinase activity and remodelling of the actin cytoskeleton are co-temporally required for degranulation by cytotoxic T lymphocytes.

Authors:  Aimee Shen; Lawrence G Puente; Hanne L Ostergaard
Journal:  Immunology       Date:  2005-10       Impact factor: 7.397

5.  Jasplakinolide induces apoptosis in various transformed cell lines by a caspase-3-like protease-dependent pathway.

Authors:  C Odaka; M L Sanders; P Crews
Journal:  Clin Diagn Lab Immunol       Date:  2000-11

6.  Role of actin cytoskeletal dynamics in activation of the cyclic AMP pathway and HWP1 gene expression in Candida albicans.

Authors:  Michael J Wolyniak; Paula Sundstrom
Journal:  Eukaryot Cell       Date:  2007-08-22

Review 7.  The Mechanistic Targets of Antifungal Agents: An Overview.

Authors:  Tryphon K Mazu; Barbara A Bricker; Hernan Flores-Rozas; Seth Y Ablordeppey
Journal:  Mini Rev Med Chem       Date:  2016       Impact factor: 3.862

8.  Genome Analysis of the Fruiting Body-Forming Myxobacterium Chondromyces crocatus Reveals High Potential for Natural Product Biosynthesis.

Authors:  Nestor Zaburannyi; Boyke Bunk; Josef Maier; Jörg Overmann; Rolf Müller
Journal:  Appl Environ Microbiol       Date:  2016-01-15       Impact factor: 4.792

9.  Use of DBA/2N mice in models of systemic candidiasis and pulmonary and systemic aspergillosis.

Authors:  R F Hector; E Yee; M S Collins
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

10.  Two new jaspamide derivatives from the marine sponge Jaspis splendens.

Authors:  Sherif S Ebada; Victor Wray; Nicole J de Voogd; Zhiwei Deng; Wenhan Lin; Peter Proksch
Journal:  Mar Drugs       Date:  2009-09-15       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.